REGN — Congress & insider trades
REGENERON PHARMACEUTICALS, INC.
1congressional trades
0 / 0buys / sells, 90 days
74insider transactions
Jul 21, 2026latest filing
Members of Congress have disclosed 1 trade in REGN (REGENERON PHARMACEUTICALS, INC.) by 1 member. In the last 90 days: 0 purchases and 0 sales. Corporate insiders filed 74 recent Form 4 transactions (0 open-market buys, 57 sells).
Members trading REGN
Congressional trades
| Disclosed | Traded | Member | Type | Amount |
|---|---|---|---|---|
| Jul 21, 2026 | Mar 27, 2026 | Alan Armstrong | Purchase | $1,001 - $15,000 |
Corporate insider trades
| Date | Insider | Role | Type | Shares | Price | |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | Pitofsky Jason | Officer, SVP Controller | Option Exercise | 1500 | 726.53 | Filing |
| Nov 4, 2026 | Pitofsky Jason | Officer, SVP Controller | Option Exercise | 1478 | 644.54 | Filing |
| Nov 4, 2026 | Pitofsky Jason | Officer, SVP Controller | Option Exercise | 905 | 492.0 | Filing |
| Nov 4, 2026 | Pitofsky Jason | Officer, SVP Controller | Sale | 439 | 939.57 | Filing |
| Nov 4, 2026 | Pitofsky Jason | Officer, SVP Controller | Sale | 575 | 940.46 | Filing |
| Nov 4, 2026 | Pitofsky Jason | Officer, SVP Controller | Sale | 982 | 941.58 | Filing |
| Nov 4, 2026 | Pitofsky Jason | Officer, SVP Controller | Sale | 1215 | 942.31 | Filing |
| Nov 4, 2026 | Pitofsky Jason | Officer, SVP Controller | Sale | 529 | 943.53 | Filing |
| Nov 4, 2026 | Pitofsky Jason | Officer, SVP Controller | Sale | 108 | 944.22 | Filing |
| Nov 4, 2026 | Pitofsky Jason | Officer, SVP Controller | Sale | 35 | 945.61 | Filing |
| Nov 4, 2026 | Pitofsky Jason | Officer, SVP Controller | Sale | 179 | 950.76 | Filing |
| Nov 3, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Gift | 1054 | 0.0 | Filing |
| Nov 3, 2026 | Zoghbi Huda Y | Director | Option Exercise | 7439 | 380.95 | Filing |
| Nov 3, 2026 | Zoghbi Huda Y | Director | Sale | 6939 | 970.42 | Filing |
| Nov 3, 2026 | Zoghbi Huda Y | Director | Sale | 500 | 971.06 | Filing |
| Nov 2, 2026 | Fenimore Christopher R. | Officer, EVP Finance CFO | Option Exercise | 6000 | 381.92 | Filing |
| Nov 2, 2026 | Fenimore Christopher R. | Officer, EVP Finance CFO | Tax Withholding | 4243 | 950.5 | Filing |
| Nov 2, 2026 | Fenimore Christopher R. | Officer, EVP Finance CFO | Gift | 15 | 0.0 | Filing |
| Nov 2, 2026 | LAROSA JOSEPH J | Officer, EVP General Counsel and Secret | Option Exercise | 12283 | 381.92 | Filing |
| Nov 2, 2026 | LAROSA JOSEPH J | Officer, EVP General Counsel and Secret | Tax Withholding | 8686 | 950.5 | Filing |
| Nov 2, 2026 | LAROSA JOSEPH J | Officer, EVP General Counsel and Secret | Sale | 3939 | 965.41 | Filing |
| Nov 2, 2026 | LAROSA JOSEPH J | Officer, EVP General Counsel and Secret | Sale | 527 | 966.11 | Filing |
| Nov 2, 2026 | SING GEORGE L | Director | Option Exercise | 7830 | 376.69 | Filing |
| Nov 2, 2026 | SING GEORGE L | Director | Option Exercise | 7439 | 380.95 | Filing |
| Nov 2, 2026 | SING GEORGE L | Director | Sale | 1224 | 960.57 | Filing |
| Nov 2, 2026 | SING GEORGE L | Director | Sale | 540 | 961.85 | Filing |
| Nov 2, 2026 | SING GEORGE L | Director | Sale | 2522 | 962.61 | Filing |
| Nov 2, 2026 | SING GEORGE L | Director | Sale | 4338 | 963.47 | Filing |
| Nov 2, 2026 | SING GEORGE L | Director | Sale | 2670 | 964.57 | Filing |
| Nov 2, 2026 | SING GEORGE L | Director | Sale | 7073 | 965.38 | Filing |
| Nov 2, 2026 | SING GEORGE L | Director | Sale | 1522 | 966.27 | Filing |
| Nov 2, 2026 | SING GEORGE L | Director | Sale | 1040 | 967.07 | Filing |
| Nov 2, 2026 | SING GEORGE L | Director | Sale | 200 | 970.18 | Filing |
| Nov 2, 2026 | POON CHRISTINE A | Director | Option Exercise | 7830 | 376.69 | Filing |
| Nov 2, 2026 | POON CHRISTINE A | Director | Sale | 218 | 966.74 | Filing |
| Nov 2, 2026 | POON CHRISTINE A | Director | Sale | 772 | 967.38 | Filing |
| Nov 2, 2026 | POON CHRISTINE A | Director | Sale | 2499 | 968.58 | Filing |
| Nov 2, 2026 | POON CHRISTINE A | Director | Sale | 3203 | 969.5 | Filing |
| Nov 2, 2026 | POON CHRISTINE A | Director | Sale | 937 | 970.51 | Filing |
| Nov 2, 2026 | POON CHRISTINE A | Director | Sale | 201 | 971.31 | Filing |
| Oct 30, 2026 | Guarini Kathryn | Director | Option Exercise | 400 | 719.37 | Filing |
| Oct 30, 2026 | Guarini Kathryn | Director | Sale | 400 | 900.0 | Filing |
| Oct 30, 2026 | McCourt Marion | Officer, EVP Commercial | Sale | 1132 | 869.43 | Filing |
| Oct 30, 2026 | BROWN MICHAEL S | Director | Option Exercise | 1929 | 725.89 | Filing |
| Oct 30, 2026 | BROWN MICHAEL S | Director | Sale | 1929 | 875.0 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 6 | 753.76 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 35 | 755.91 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 16 | 757.68 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 24 | 758.16 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 14 | 759.96 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 74 | 760.65 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 27 | 761.36 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 55 | 762.57 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 25 | 763.76 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 219 | 764.4 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 271 | 765.39 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 279 | 766.47 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 192 | 767.39 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 105 | 768.33 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 127 | 769.3 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 12 | 770.2 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 283 | 771.56 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 211 | 772.56 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 224 | 773.4 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 121 | 774.48 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 376 | 775.46 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 66 | 776.31 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 38 | 777.76 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 454 | 778.64 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 380 | 779.59 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 463 | 780.63 | Filing |
| Oct 14, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Sale | 50 | 781.47 | Filing |
| Oct 13, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Option Exercise | 17000 | 381.92 | Filing |
| Oct 13, 2026 | MURPHY ANDREW J | Officer, Co-Chief Scientific Officer | Tax Withholding | 12853 | 754.58 | Filing |